<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(1)</volume><submitter>Aljaberi N</submitter><pubmed_abstract>BACKGROUND:Serum phagocyte-derived alarmins S100A8/9 and S100A12 are considered useful for the assessment of inflammatory diseases. Our study evaluated the use of S100 proteins in a pediatric clinical setting for estimating disease activity and supporting diagnosis. METHODS:Patients (n = 136) who had S100 proteins tested as part of clinical care were included in this study and relevant information obtained from the medical record: C-reactive protein (CRP), disease activity status (inactive: = 0 joint; active: > 0 active joint), systemic symptoms in systemic JIA (sJIA), and symptoms of flare of other autoinflammatory and fever syndromes. Patients were categorized as: sJIA, non-systemic JIA (nsJIA), other defined autoinflammatory syndromes (AID) and systemic undifferentiated recurring fever </pubmed_abstract><journal>Pediatric rheumatology online journal</journal><pagination>7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6966841</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.</pubmed_title><pmcid>PMC6966841</pmcid><pubmed_authors>Henrickson M</pubmed_authors><pubmed_authors>Schulert G</pubmed_authors><pubmed_authors>Grom AA</pubmed_authors><pubmed_authors>Aljaberi N</pubmed_authors><pubmed_authors>Brunner HI</pubmed_authors><pubmed_authors>Tronconi E</pubmed_authors><pubmed_authors>Huggins JL</pubmed_authors><pubmed_authors>Lovell DJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.</name><description>BACKGROUND:Serum phagocyte-derived alarmins S100A8/9 and S100A12 are considered useful for the assessment of inflammatory diseases. Our study evaluated the use of S100 proteins in a pediatric clinical setting for estimating disease activity and supporting diagnosis. METHODS:Patients (n = 136) who had S100 proteins tested as part of clinical care were included in this study and relevant information obtained from the medical record: C-reactive protein (CRP), disease activity status (inactive: = 0 joint; active: > 0 active joint), systemic symptoms in systemic JIA (sJIA), and symptoms of flare of other autoinflammatory and fever syndromes. Patients were categorized as: sJIA, non-systemic JIA (nsJIA), other defined autoinflammatory syndromes (AID) and systemic undifferentiated recurring fever </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2025-04-26T06:19:02.49Z</modification><creation>2020-05-22T08:25:22Z</creation></dates><accession>S-EPMC6966841</accession><cross_references><pubmed>31948488</pubmed><doi>10.1186/s12969-020-0398-2</doi></cross_references></HashMap>